294MO Preoperative window-of-opportunity study with giredestrant or tamoxifen (tam) in premenopausal women with estrogen receptor-positive (ER+)/human epidermal growth factor receptor 2-negative (HER2-) and Ki67≥10% early breast cancer (EBC): The EMPRESS study
作者
A. Llombart Cussac,G. Viale,Manuel Ruíz Borrego,V. Carañana Ballerini,Elena López-Miranda,Isabel Blancas,Laia Garrigós,M. Gion Cortes,M. López Flores,A.L. Guerrero Zotano,Cristina Saavedra,J.M. Cejalvo,J. De la Haba Rodriguez,C.R. Albacar Miro,M. Aguiló,José Antonio López‐Guerrero,Pari Skamnioti,Jacques Médioni,J.M. Perez Garcia,J.‐C. Cortés
PDF的下载单位、IP信息已删除
(2025-6-4)
Nole
Criminology34
小小牛马
张欢馨
Essence
lucky
东方元语
sanvva
GingerF
乐空思
OK
luang
一介书生
赵赶超
dde
初景
vampv
龙06
yjh123
Kao
皖公网安备34019202002308
